Anurag R Lila

Dr. Anurag R Lila

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Endocrine Practice
Verified
Journal Article
Closed access
ALAnurag R Lila
Anurag R Lila
RGRaju A. Gopal
Raju A. Gopal
SAShrikrishna V. Acharya
Shrikrishna V. Acharya
JGJoe George
Joe George
VSVijaya Sarathi
Vijaya Sarathi
NSNalini S. Shah
Nalini S. Shah

1 October 2019 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
RSRavikumar Shah
Ravikumar Shah
ALAnurag R Lila
Anurag R Lila
RJRamteke-Swati Jadhav
Ramteke-Swati Jadhav
VPVirendra Patil
Virendra Patil
AMAbhishek Mahajan
Abhishek Mahajan
TBTushar Bandgar
Tushar Bandgar
Tumor-induced osteomalacia in the head and neck region remains a challenging diagnosis to manage. Literature pertaining to management and outcome details remains sparse. We describe two cohorts: cohort 1 included seven patients from a single center in Western India with tumors located in paranasal sinuses ( n = 3), intracranial ( n = 2) and maxilla ( n = 2). The unique features from our series is the management of persistent disease with radiation therapy ( n = 2) and peptide receptor radionuclide therapy (PRRT) ( n = 1). Cohort two has 163 patients identified from 109 publications for systematic review. Paranasal sinuses, mandible, intracranial disease, maxilla and oral cavity, in descending order, are reportedly common tumor sites. Within this cohort, mean age was 46 ± 14 years at presentation with 44.1% having local symptoms. Duration of symptoms varied from 1 to 240 months. Pre-surgery mean serum phosphorus was 1.4 ± 0.4 mg/dL and median FGF-23 levels were 3.6 (IQR:1.8–6.8) times of normal upper limit of normal. Majority (97.5%) were managed primarily with surgical excision; however, primary radiotherapy ( n = 2) and surgery combined with radiotherapy ( n = 2) were also reported. Twenty patients had persistent disease while nine patients had recurrence, more commonly noted with intracranial and oral cavity tumors. Surgery was the most common second mode of treatment employed succeeded by radiotherapy. Four patients had metastatic disease. The most common histopathological diagnosis reported is PMT mixed connective tissue, while the newer terminology ‘PMT mixed epithelial and connective tissue type’ has been described in 15 patients.

1 January 2012 in Indian Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ALAnurag R Lila
Anurag R Lila
VSVijaya Sarathi
Vijaya Sarathi
VJVarsha Jagtap
Varsha Jagtap
TBTushar Bandgar
Tushar Bandgar
PMPadma S Menon
Padma S Menon
NSNalini Samir Shah
Nalini Samir Shah
Primary hyperparathyroidism (PHPT) is associated with nephrolithiasis and nephrocalcinosis. Hypercalciuria is one of the multiple factors that is implicated in the complex pathophysiology of stone formation. The presence of a renal stone (symptomatic or asymptomatic) categorizes PHPT as symptomatic and is an indication for parathyroid adenomectomy. Progression of nephrocalcinosis is largely reversible after successful surgery, but the residual risk persists. PHPT is also associated with declining renal function. In case of asymptomatic mild PHPT, annual renal functional assessment is advised. Guidelines suggest that an estimated glomerular filtration rate (eGFR) < 60 ml / minute / 1.73 m 2 is an indication for parathyroid adenomectomy. This article discusses how to monitor and manage renal stones and other related renal parameters in case of PHPT.

1 January 2021 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
RSRavikumar Shah
Ravikumar Shah
RGRobin Garg
Robin Garg
MMMonil Majmundar
Monil Majmundar
NPNilendu Purandare
Nilendu Purandare
GMGaurav Malhotra
Gaurav Malhotra
TBTushar Bandgar
Tushar Bandgar

1 November 2017 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
PBPrachi Bansal
Prachi Bansal
ALAnurag R Lila
Anurag R Lila
MGManjunath Goroshi
Manjunath Goroshi
SJSwati Jadhav
Swati Jadhav
NLNilesh Lomte
Nilesh Lomte
NSNalini Shah
Nalini Shah
Purpose: Transsphenoidal surgery (TSS) is the primary treatment modality for Cushing’s disease (CD). However, the predictors of post-operative remission and recurrence remain debatable. Thus, we studied the post-operative remission and long-term recurrence rates, as well as their respective predictive factors. Methods: A retrospective analysis of case records of 230 CD patients who underwent primary microscopic TSS at our tertiary care referral centre between 1987 and 2015 was undertaken. Demographic features, pre- and post-operative hormonal values, MRI findings, histopathological features and follow-up data were recorded. Remission and recurrence rates as well as their respective predictive factors were studied. Results: Overall, the post-operative remission rate was 65.6% (early remission 46%; delayed remission 19.6%), while the recurrence rate was 41% at mean follow-up of 74 ± 61.1 months (12–270 months). Significantly higher early remission rates were observed in patients with microadenoma vs macroadenoma (51.7% vs 30.6%, P = 0.005) and those with unequivocal vs equivocal MRI for microadenoma (55.8% vs 38.5%, P = 0.007). Patients with invasive macroadenoma had poorer (4.5% vs 45%, P = 0.001) remission rates. Recurrence rates were higher in patients with delayed remission than those with early remission (61.5% vs 30.8%, P = 0.001). Duration of post-operative hypocortisolemia ≥13 months predicted sustained remission with 100% specificity and 46.4% sensitivity. Recurrence could be detected significantly earlier (27.7 vs 69.2 months, P < 0.001) in patients with available serial follow-up biochemistry as compared to those with infrequent follow-up after remission. Conclusion: In our study, remission and recurrence rates were similar to that of reported literature, but proportion of delayed remission was relatively higher. Negative/equivocal MRI findings and presence of macroadenoma, especially those with cavernous sinus invasion were predictors of poor remission rates. In addition to early remission, longer duration of post-operative hypocortisolism is an important predictor of sustained remission. Regular biochemical surveillance may help in identifying recurrence early.

17 September 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
MSManjeetkaur Sehemby
Manjeetkaur Sehemby
ALAnurag R Lila
Anurag R Lila
VSVijaya Sarathi
Vijaya Sarathi
RSRavikumar Shah
Ravikumar Shah
SSShilpa Sankhe
Shilpa Sankhe
TBTushar Bandgar
Tushar Bandgar
Context: Data are limited regarding prevalence, predictors, and mechanisms of persistent hypogonadotropic hypogonadism (HH) in males with a macroprolactinoma who achieve normoprolactinemia on dopamine-agonist therapy. None of the previous studies provide cutoffs to predict the achievement of eugonadism. Objective: The objective of this work is to evaluate the prevalence of persistent HH and its determinants in men with a macroprolactinoma who achieve normoprolactinemia on cabergoline monotherapy. Design and Setting: This retrospective study with prospective cross-sectional evaluation took place at a tertiary health care center. Patients: Study participants included men with a macroprolactinoma and baseline HH who achieved normoprolactinemia on cabergoline monotherapy. Main Outcome Measures: Outcome measures of this study included the prevalence of persistent HH and its predictors. Results: Thirty participants (age, 38.3 ± 10.1 years) with baseline tumor size of 4.08 ± 1.48 cm and median (interquartile range) prolactin of 2871 ng/mL (range, 1665-8425 ng/mL) were included. Eight of 30 participants achieved eugonadism after a median follow-up of 3 years. Patients with persistent HH had suppression of the luteinizing hormone (LH)-testosterone axis with sparing of other anterior pituitary hormonal axes, including follicle-stimulating hormone-inhibin B. Baseline prolactin (1674 vs 4120 ng/mL; P = .008) and maximal tumor diameter (2.55 ± 0.36 vs 4.64 ± 1.32 cm; P = .003) were lower in patients who achieved eugonadism. Baseline maximal tumor diameter less than or equal to 3.2 cm (sensitivity: 75%, specificity: 63.6%) and serum prolactin less than or equal to 2098 ng/mL (sensitivity: 87.5%, specificity: 77.3%) best predicted reversal of HH. Conclusion: Recovery of the LH-testosterone axis occurred in 26.7% of men with a macroprolactinoma who achieved normoprolactinemia on cabergoline monotherapy. Higher baseline tumor size and serum prolactin predict persistent HH. Our data favor chronic functional modification of the hypothalamic-pituitary-gonadal axis over gonadotroph damage as the cause of persistent HH.